Nature 560 , 499503 (2018)
Oral peptide therapy requires thorough medical evaluation and ongoing monitoring
F.MegsonI
7: Masnec S, Kokot A, Kralj T, Zlatar M, Loncaric K, Sablic M, Kalauz M, Beslic I, Oroz K, Mrvelj B, Beketic Oreskovic L, Oreskovic I, Strbe S, Staresinic B, Slivsek G, Boban Blagaic A, Seiwerth S, Skrtic A, Sikiric P
30 An early peak in acute pancreatitis also occurred within the first 60 days of starting therapy in the SCALE trial
BPC-157 5mg Vial: 5mg lyophilised BPC-157 Stock solution: 2 mL solvent 2.5 mg/mL 250 mcg aliquot: transfer 0.1mL (100 L) TB-500 5mg Vial: 5mg lyophilised TB-500 Stock solution: 2 mL solvent 2.5 mg/mL 500 mcg aliquot: transfer 0.2mL (200 L) GHK-Cu 50mg Vial: 50mg lyophilised GHK-Cu Stock solution: 5 mL solvent 10 mg/mL 1 mg aliquot: transfer 0.1mL (100 L) CJC-1295 2mg Vial: 2mg lyophilised CJC-1295 Stock solution: 2 mL solvent 1 mg/mL 100 mcg aliquot: transfer 0.1mL (100 L) Frequently asked questions How do I reconstitute lyophilised peptides